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Abstract  
Introduction: Steroid cell tumors of the ovary present less than 0.1% of all ovarian tumors and 
belong in the group of sex cord-stromal tumors.  
Case description: We present a case of 69-year-old woman investigated because of 
postmenopausal bleeding, a 5-year history of excessive hirsutism, baldness and acne. The 
evaluation revealed elevated serum testosterone, but ultrasound detected a 2 cm-mass of the left 
ovary. The patient underwent hysterectomy and bilateral adnexectomy. The histopathology 
diagnosis was steroid cell tumor, not otherwise specified. Postoperative chemotherapy was 
administered at the discretion of the radio-oncologist. At the last follow-up 48 months after surgery, 
the hirsutism was completely resolved, the serum testosterone was within the normal range and 
there was no evidence of recurrence. 
Conclusion: In adult patients with hirsutism and elevated serum testosterone a possibility of a 
presence of an ovarian steroid cell tumor should be considered. Surgery is the main treatment of 
such patients.  
 
 
 
 
 
 
Introduction 
Steroid cell tumors of the ovary account for 
less than 0.1% of all ovarian tumors [1]. These tumors 
may present at any age in association with interesting 
presentations related to the hormonal activity and 
virilizing properties of tumor. Hayes and Scully [2] 
reported 63 cases in patients ranging from 2 to 80 
years of age. The subtype, not otherwise specified, is 
associated with androgenic changes in approximately 
one half of patients with this tumor [1]. In a series of 
63 cases from Massachusetts General Hospital, 94% 
of the tumors were found to be unilateral and 28.6% 
were malignant [3]. As most of these tumors are 
diagnosed at an early stage and do not recur or 
metastasize, little is known about their response to 
therapies such as chemotherapy or radiation [3]. 
We report the case of a virilizing ovarian 
tumor in a postmenopausal woman, which presented 
with recidivant postmenopausal metrorrhagia and 
evident hirsutism. The diagnosis of the tumor site was 
made using preoperative pelvic ultrasonography, 
quatitative measurement of testosterone levels in 
blood samples and laparoscopic visualization, thereby 
leading to hysterectomy with bilateral adnexectomy. 
 
Case Description 
This is the case of a 69-year-old woman, 
admitted at our University Clinic of Obstetrics and 
Gynecology in Mars 2008 because of a 5-year history 
of excessive hirsutism, baldness, acne and recurrent 
postmenopausal uterine bleeding since October 2005. 
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She had had normal menstrual cycles since menarche 
and her last menstruation was 15 years ago. Her 
hirsutism had developed within the last 5 years and 
had become more severe within the last year. The 
patient did not report any alteration regarding her 
libido. She denied any changes in her voice and 
muscle mass. She had two children and two artificial 
abortions in her generative history. Her family history 
was unremarkable. She had not taken any hormones 
or had any previous surgeries. Because of a recurrent 
postmenopausal uterine bleeding she had three 
explorative curettages (in October 2005, in September 
2006 and in February 2008). The histopathological 
analyses revealed only an atrophic endometrium. 
Physical examination revealed a grade I 
obese woman (body mass index of 30.6 kg/m
2
), with 
male pattern baldness i.e. parietal temporal baldness, 
facial skin acne, and marked hirsutism, i.e. a male 
pattern of coarser hair distribution in the beard region, 
anterior chest wall, abdomen and extremities (grade 
15 of the Ferriman & Gallwey score, normal < 9) (4). 
Her voice was feminine and her muscle mass was 
slightly enlarged. The systolic blood pressure was 160 
mmHg and diastolic one 100 mmHg and heart rate 
was 85/min. There were no striae or bruises. The 
patient had no specific symptoms of Cushing’s 
syndrome. No acanthosis nigricans was noted. The 
breasts were atrophic, without masses or 
galactorrhea. The abdominal palpation did not provide 
additional information. 
Vaginal examination revealed mild clitoral 
enlargement. No adnexal mass was palpable. The 
cytology test of cervical smear revealed only atrophy 
with inflammation.  
The transvaginal ultrasound examination of 
the ovaries, performed by two different gynecologists 
revealed a solid hyperechogenic mass into the 
structure of the left ovary, measuring 23 × 18 × 22 mm 
with moderate to significant vascularity. There was no 
ascites, retroperitoneal lymphadenopathy, adrenal 
gland enlargement, or liver metastasis. No 
pathological signs were detected on the X ray 
examination. 
The initial laboratory investigation revealed a 
normal blood cell count, electrolyte level and liver and 
renal function tests within normal range. 
Cushing syndrome was ruled out by an 
overnight dexamethasone suppression test (1 mg – 
cortisol <1.0 μg/dL), primary hyperaldosteronism by 
the measurement of serum potassium (4.3 mEq/L) 
and aldosterone (3.3 ng/dL).  
In addition, hormone levels were evaluated. 
The serum levels of estradiol and follicle-stimulating 
hormone were into the normal ranges for 
postmenopause, thyroid-stimulating hormone was 
also in normal range, and sex hormone-binding 
globulin (SHBG) levels were at the lower limit of the 
normal range. The patient had high serum 
testosterone (17.3 nmol/l) (normal range: 0.19-2.67 
nmol/l), which implied the diagnosis of a virilizing 
tumor. Serum dehydroepiandrosterone sulfate 
(DHEAS) and androstendion were normal, which 
argued against an adrenal source of testosterone. The 
increase in testosterone levels during human 
chorionic gonadotropin (hCG) administration (5000 
IU/d for 3 days) was consistent with the hypothesis of 
an ovarian virilizing tumor. The tumor marker CA-125, 
as well as beta-human chorionic gonadotropin (HCG) 
and alpha-fetoprotein were into the normal ranges. 
An ovarian virilizing tumor, as a source of 
hypertestosteronemia was supposed and the patient 
was advised to undergo surgery. She underwent 
diagnostic laparoscopy, during which a sample from 
peritoneal washing was taken. It discovered only 
mature lymphocytes, but no malignant cells. The right 
ovary, womb and all peritoneal surfaces were normal. 
A yellow-coloured tumor measuring 2 cm was found in 
the left ovary. The final surgical procedure included 
hysterectomy with bilateral salpingo-oophorectomy. 
 
 
 
Figure 1: Steroid cell tumor not otherwise specified: low power view 
showing the tumor mass clearly separated from the normal ovarian 
cortex with corpora albicantia (1a, hematoxylin and eosin stain, 
original magnification: x50); the high power shows variably sized, 
round to polygonal tumor cells, with granular, eosinophylic or less 
frequently more abundant vacuolated cytoplasm and round nuclei 
with prominent nucleoli (1b, hematoxylin and eosin stain, original 
magnification: x200). 
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Grossly the uterine corpus measured 5.5 x 
4.5 x 4 cm, and the dimensions of the uterine cervix 
were 4.2 x 3 x 1.4 cm. A polypoid mass 13 mm in 
diameter was attached to the mucosa of the anterior 
uterine wall, while an intramural leiomyoma measuring 
17 mm was dissected in the right uterine wall. Both 
adnexa were of normal size (right ovary: 3 x 2 x 1 cm; 
left ovary: 3 x 2.5 x 1 cm) and were externally 
unremarkable. A cut section of the left ovary showed a 
well circumscribed, yellowish-brown solid nodule 17 
mm in diameter. 
 
  
  
  
Figure 2: Immunohistochemical results: the neoplastic cells were diffusely immunoreactive for vimentin (2a, diaminobenzidine, x200), 
calretinin (2b, diaminobenzidine, x200), alpha-inhibin (2c, diaminobenzidine, x200), CD56 (2d, diaminobenzidine, x200).and melan A (2e, 
diaminobenzidine, x200), and focally for pan-cytokeratin (2f, diaminobenzidine, x200). 
 
Histopathology confirmed a 17 mm steroid 
tumor of the left ovary localized next to the ovarian 
hilum. Superiorly the mass was covered by a 1-7 mm 
thick crescent of ovarian cortex with corpora albicantia 
and a number of arterioles with thick hyaline walls 
(Figure 1a). The tumor was unencapsulated, and 
composed of tumor cells arranged diffusely or in some 
other areas in small nests and clusters, separated by 
scant, delicate or focally more abundant intervening 
fibrous stroma with hyalinization. Tumor cells were 
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round to polygonal, with distinct cell membranes. Most 
of the cells were medium-sized and had finely 
granulated, eosinophilic cytoplasm. Less frequently 
the cells were large in size with vacuolated cytoplasm 
(Figure 1b). Some of these cells contained small lipid 
droplets as demonstrated by oil-red O stain. 
Intracytoplasmic lipochrome pigment was also present 
in a small number of cells. The nuclei were round and 
centrally placed, frequently with prominent small 
single nucleoli. Crystals of Reinke were not observed. 
No nuclear atypia was found and at most one mitosis 
per 10 high power fields (x400) was counted. There 
were no foci of necrosis or hemorrhage present. 
Immunohistochemistry staining demonstrated that the 
tumor cells were diffusely positive for vimentin, alpha-
inhibin, calretinin, melan A, CD99, and CD56, and 
focally positive for pan-cytokeratin (Figure 2a-f). 
These findings were consistent with a steroid cell 
tumor, not otherwise specified of the left ovary which 
lacked the unfavorable histological features 
associated with malignant behavior.  
In the right ovary only corpora albicantia as 
well as mesonephric remnants in the medulla were 
present. Histopathological examination of the sections 
taken from the uterus revealed that the endometrium 
was atrophic, as well as the presence of a senile 
endometrial polyp, small intramural leiomyoma and 
chronic inflammation with rare ovula Nabothi in uterine 
cervix. 
The early postoperative period was regular 
and patient was dismissed from the hospital on the 
seventh postoperative day. An additional 
chemotherapy was administrated at the University 
Clinic of Radiotherapy and Oncology, at the discretion 
of radio oncologist (four cycles of Carboplatin à 500 
mg/m
2
). At the first follow-up controls (3 months after 
the operation), the hirsutism was completely resolved, 
the serum testosterone was into the normal range (0.5 
nmol/l) and the androgenic alopecia almost 
completely reversed. The patient is being followed up 
with regular measurement of serum testosterone and 
pelvic ultrasound examination every 6 months for 
early diagnosis of disease recurrence. At the last 
follow-up 48 months after surgery she was in good 
condition, the hirsutism and alopecia were completely 
resolved, and no relapse of the disease was found. 
 
Discussion 
The diagnosis of ovarian virilizing tumors can 
be difficult in women of any generative age, because 
the size of such tumors is often too small to allow 
detection by ultrasound or radiological examination 
[5]. Many histological tumor types have been 
described, and different classifications have been 
proposed. The most frequent type is the Sertoli-Leydig 
cell tumor arrhenoblastoma, which is observed in 
premenopausal women. Eighty percent of such 
tumors result in hyperandrogenism [6]. They are small 
tumors (less than 4 cm in diameter), unilateral in more 
than 95% of cases, with excellent prognosis because 
almost all of them are benign. Hilar Leydig cell tumors 
are more often observed in postmenopausal women 
and are gonadotropin dependent. The rare hilar non-
Leydig cell tumors that are diagnosed in younger 
women belong to another histological type classified 
as nonspecific tumors. Only 50% of them are 
associated with hyperandrogenism, and 20-40% are 
malignant [7]. However, when located in the hilum, 
they are more likely to be benign, and a small size is a 
criterion for better prognosis. Regnier et al. [8] 
reported a very rare case of simultaneous presence of 
Leydig cell tumor of the ovary and adrenal 
incidentaloma in a 41-year-old female patient, referred 
for evaluation of hirsutism that had increased within 
the previous 3 years.  
The classical microscopic findings of steroid 
cell tumors include cells which can be diffusely 
arranged or arranged into nests, clusters, cords and 
columns. Steroid cell tumors lack crystals of Reinke. 
Immunohistochemistry helps in the distinction 
between steroid cell tumors of the ovary and other 
primary or metastatic ovarian neoplasms [9]. There 
are three subtypes of these tumors: stromal luteoma, 
Leydig cell tumor (hilus and non-hilus cell type) and 
steroid cell tumor (not otherwise specified). The 
steroid cell tumor (not otherwise specified) is larger 
and may secrete adrenal cortex steroid hormones that 
can induce hypercortisolism, also known as Cushing 
syndrome [10]. Nevertheless, pathologically benign 
steroid cell tumors can behave in a clinically malignant 
fashion. Therefore, about 20% of patients develop 
metastatic lesions in peritoneal cavity, and rarely at 
distant sites. Their primary treatment is surgical 
extirpation of the primary lesion, but there are no 
reports of effective radiation or chemotherapy 
because of the rarity of this tumor. In recent years, the 
use of gonadotropin releasing hormone (GnRH) 
agonists promises in non-surgical cure with 
suppression effect on hormone secretion and leading 
to apoptosis of cells, as well.  
Hirsutism, which can be defined as excessive 
growth of androgen-dependent sexual hair, is one of 
the manifestations of these tumors, as a result of 
increased androgen production of the tumor tissue 
[11]. It can be isolated or associated with other signs 
of increased androgen levels, such as: menstrual 
disturbances, acne, deepening of the voice, increase 
in muscle mass, clitoromegaly, breast hypotrophy and 
frontoparietal balding.  
Especial difficulties arise in the differential 
diagnosis of steroid cell tumors from other possible 
causes of hirsutism in perimenopause. Apart of 
iatrogenia and steroid cell ovarian tumors, other 
possible causes of hirsutism in perimenopause could 
be nonclassical congenital adrenal hyperplasia, 
ovarian hyperthecosis or adrenal tumors. This 
differential diagnosis is important, since 
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adrenal/ovarian tumors can be life-threatening 
conditions and deserve surgical treatment. On the 
other hand, the ovarian hyperthecosis, as a part of the 
HAIR-AN syndrome, is a result of hyperplasia/ 
luteinization of the cortical stroma. Its basic 
physiological mechanism during the premenopuausal 
age is a presence of severe insulin resistance, while 
in the postmenopause, it is due to the continuous 
stimuli of elevated gonadotropins [12, 13]. In 
postmenopause, the hyperandrogenic syndrome is 
unrelated to insulin resistance, but it is result of 
continuous increasing levels of luteinizing hormone 
[14]. The hallmark of this syndrome is an increase in 
bilateral ovarian volume, although unilateral increase 
in ovarian volume has been described [15]. Only a few 
women with hyperthecosis have been treated with a 
gonadotropin releasing hormone (GnRH) agonist, but 
all had a substantial decrease in serum androgen 
concentrations.  
Hayes and Scully [2] have identified five 
pathologic features of the steroid cell tumors 
associated with malignancy: 1) more than two mitoses 
per high-power field; 2) necrosis; 3) size of 7 cm or 
larger; 4) hemorrhage; 5) grade 2 or 3 of nuclear 
atypia. In our case, none of them was present. The 
characteristic pattern of immunohistochemistry 
staining for inhibin, calretinin, melan A, CD99, and 
CD56, along with the positivity for and vimentin and 
anti-human cytokeratin, as well as and distinct cell 
borders with the absence of Reinke's crystals are 
crucial for diagnosis [9]. All abovementioned patterns 
were present in our case.  
Choudhary et al. [16] reported a case of 
steroid cell tumor in 50-year-old women with 
hirsutism, clitoromegaly and frontal baldness, elevated 
serum testosterone level and normal DHEA-sulfate, 
which is very similar to our case.  
The presence of an adrenal tumor could be 
another cause for hirsutism in postmenopausal age. In 
all androgen-producing ovarian tumors, serum 
testosterone level is elevated in conjunction with 
normal or mildly elevated serum DHEAS levels, but 
the increased dehydroepiandrosterone sulphate levels 
are often associated with adrenal tumors [17]. A 
dexamethasone suppression test may be useful to 
help distinguish between ovarian and adrenal sources 
of androgens. We had also applied this test in the 
preoperative investigation. 
Our case is interesting because of the 
recurrent episodes of postmenopausal metrorrhagia 
required explorative curettage. The ultrasound 
investigation revealed a small solid tumor 2 cm in 
diameter of the left ovary, in spite of the fact that the 
tumor was nonpalpable. The presence of signs of 
virilization and hypertestosteronemia led us to right 
diagnosis and adequate treatment.  
In recent years attempts have been made 
with the use of gonadotropin releasing hormone 
(GnRH) analogues for suppression of secretion and 
non-surgical cure. These approaches have been tried 
especially in non-operable cases or recurrent disease. 
Therefore, at best, these treatments can be 
considered experimental at the present time. Further 
insight into the nature, biology and behavior of these 
tumors may change the gold standard of treatment 
from surgical extirpation to medical management over 
time. 
In women with recent-onset or rapidly 
progressive hirsutism, with or without normal 
menstrual cycles, measurement of testosterone levels 
and detailed pelvic ultrasound examination are 
mandatory to screen for virilizing tumors. Our case 
was interesting because of the presentation with 
recurrent postmenopausal metrorrhagia and signs of 
virilization due to hypertestosteronemia which helped 
us to make a correct diagnosis and treatment of the 
patient. The primary treatment is still surgical 
extirpation, because of the fact that some of these 
tumors have malignant potential. In some cases, an 
additional oncological treatment could be 
recommended. 
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